Guillian Fleming
Family · Kingsport, TNNPI 1851468524
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Novo Nordisk at 26.2% of the total. Reporting peaked in 2021 at $1,151 and has fallen 98.5% since, to $17 in 2023.
Across 81 payments — averaging $14.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$317
- AbbVie$190
- Amgen$102
- Esperion Therapeutics, Inc.$76
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$54
- Boehringer Ingelheim$47
- plus $426 from 17 others
What the payments were for
- Food & beverage$1,212100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 25 | $317 |
| AbbVie(2 entities) | 14 | $190 |
| Amgen(2 entities) | 7 | $102 |
| Esperion Therapeutics, Inc. | 3 | $76 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $54 |
| Boehringer Ingelheim | 2 | $47 |
| Astellas Pharma US Inc | 1 | $45 |
| GSK | 3 | $45 |
| Biohaven Pharmaceuticals, Inc. | 2 | $44 |
| Eisai Inc. | 3 | $38 |
| Lilly USA, LLC | 2 | $33 |
| Daiichi Sankyo Inc. | 2 | $30 |
| Novartis | 2 | $27 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Clarus Therapeutics Inc. | 2 | $19 |
| Pfizer | 1 | $17 |
| Antares Pharma, Inc. | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Bayer | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $15 |
| Merck | 1 | $12 |
| AstraZeneca | 1 | $12 |
How this compares
$1,212 in reported general payments places this provider in the 65th percentile of 6,706 family providers in Tennessee.
Other family in Kingsport
- Tracie PriceKingsport$49K
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
- Chantil JeffreysGermantown$195K
- Laura PorchCordova$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.